JPRN-UMIN000046418已完成未知
Registry Study of Immune-Related Adverse Events using ePRO in Cancer Patients Receiving Immune Checkpoint Inhibitors - RESPECT study
MHLW(Japan)0 个研究点目标入组 260 人开始时间: 2021年12月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 260
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.does not have a device that can be used with ePRO 2.severe psychiatric disorder 3.cognitive impairment that may affect the completion of the questionnaire 4.native language is not Japanese
研究者
相似试验
已完成
不适用
eurological immune-related adverse events in checkpoint Inhibitor therapyneurological (immune-related) adverse Events in checkpoint inhibitor therapyDRKS00019080niversitätsklinikum Essen66
已完成
不适用
Side Effects of Anti-PD-(L)-1 and Anti CTLA-A4 in the Non Small Cells Lung CancerCarcinoma, Non-Small-Cell LungDrug-Related Side Effects and Adverse ReactionsNCT03125603Cliniques universitaires Saint-Luc- Université Catholique de Louvain80
招募中
不适用
Immune Related Rheumatological Adverse Events. Data collection from patients with cancer to evaluate rheumatological adverse events in patients treated with immune-checkpoint inhibitors.Rheumatological side effects to therapy1000381610027655NL-OMON54205Vrije Universiteit Medisch Centrum495
已完成
不适用
EXploring Immune-related Adverse Events of Immune checkpoinT Inhibitors Using VigiBase, the WHO Pharmacovigilance DatabaseImmune-related Adverse EventImmune Checkpoint Inhibitor-Related MyocarditisCancerNCT05934214Groupe Hospitalier Pitie-Salpetriere141,630
招募中
不适用
Analysis of immune-related adverse event by immune checkpoint inhibitorpatients treated by immune checkpoint inhibitorJPRN-UMIN000031806Chiba University180